TG Therapeutics | TGTX - Trade Debtors


TG Therapeutics reported $401.56M in Trade Debtors for its fiscal quarter ending in June of 2026.





Trade Debtors Change Date
AbbVie USD 12.48B 110M Mar/2026
Alaunos Therapeutics USD 2K 0 Jun/2025
Amgen USD 10.23B 1.09B Jun/2026
Ardelyx USD 82.84M 10.99M Mar/2026
Arrowhead Research USD 8.56M 7.13M Jun/2026
Bayer EUR 18.7B 146M Jun/2026
Biogen USD 1.79B 76.6M Mar/2026
Corcept Therapeutics USD 76.92M 37.85M Jun/2026
Curis USD 2.55M 400K Jun/2024
Gilead Sciences USD 5.06B 314M Jun/2026
J&J USD 19.05B 3.49B Jun/2026
Karyopharm Therapeutics USD 23.36M 2.82M Mar/2026
Novartis USD 9.85B 252M Jun/2026
Novavax USD 106.45M 72.27M Dec/2025
PTC Therapeutics USD 219.92M 38.3M Mar/2026
Puma Biotechnology USD 28.1M 3.52M Jun/2024
Regeneron Pharmaceuticals USD 6.57B 834.4M Jun/2026
Roche Holding CHF 13.34B 1.44B Jun/2026
TG Therapeutics USD 401.56M 9.52M Jun/2026
Verastem USD 10.36M 1.34M Mar/2026
Vertex Pharmaceuticals USD 2.13B 138.2M Jun/2026